Autoantibodies against cytoskeletons and lysosomal trafficking discriminate sarcoidosis from healthy controls, tuberculosis and lung cancers.

Mol Biomed · 2022 · PMC8770712 · PMID 35048206

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Decreasing the FDR threshold to 0.01, we identified 14 highly significant clones differentially reactive in sarcoidosis versus healthy controls.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.